SBC MEDICAL GROUP HOLDINGS I (SBC) Fundamental Analysis & Valuation

NASDAQ:SBC • US73245B1070

Current stock price

3.63 USD
+0.13 (+3.71%)
At close:
3.63 USD
0 (0%)
After Hours:

This SBC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. SBC Profitability Analysis

1.1 Basic Checks

  • In the past year SBC was profitable.
  • In the past year SBC has reported a negative cash flow from operations.
SBC Yearly Net Income VS EBIT VS OCF VS FCFSBC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 20M 40M 60M 80M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 13.48%, SBC belongs to the top of the industry, outperforming 98.02% of the companies in the same industry.
  • The Return On Equity of SBC (17.47%) is better than 85.15% of its industry peers.
  • SBC's Return On Invested Capital of 21.24% is amongst the best of the industry. SBC outperforms 97.03% of its industry peers.
Industry RankSector Rank
ROA 13.48%
ROE 17.47%
ROIC 21.24%
ROA(3y)11.06%
ROA(5y)N/A
ROE(3y)17.35%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SBC Yearly ROA, ROE, ROICSBC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 10 20 30

1.3 Margins

  • SBC's Profit Margin of 24.28% is amongst the best of the industry. SBC outperforms 100.00% of its industry peers.
  • With an excellent Operating Margin value of 41.70%, SBC belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • SBC has a better Gross Margin (74.09%) than 90.10% of its industry peers.
Industry RankSector Rank
OM 41.7%
PM (TTM) 24.28%
GM 74.09%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SBC Yearly Profit, Operating, Gross MarginsSBC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. SBC Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), SBC is creating value.
  • Compared to 1 year ago, SBC has less shares outstanding
  • The debt/assets ratio for SBC has been reduced compared to a year ago.
SBC Yearly Shares OutstandingSBC Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 20M 40M 60M 80M 100M
SBC Yearly Total Debt VS Total AssetsSBC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

  • SBC has an Altman-Z score of 6.03. This indicates that SBC is financially healthy and has little risk of bankruptcy at the moment.
  • SBC's Altman-Z score of 6.03 is amongst the best of the industry. SBC outperforms 91.09% of its industry peers.
  • A Debt/Equity ratio of 0.07 indicates that SBC is not too dependend on debt financing.
  • SBC has a better Debt to Equity ratio (0.07) than 78.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Altman-Z 6.03
ROIC/WACC2.46
WACC8.64%
SBC Yearly LT Debt VS Equity VS FCFSBC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 5.10 indicates that SBC has no problem at all paying its short term obligations.
  • The Current ratio of SBC (5.10) is better than 93.07% of its industry peers.
  • A Quick Ratio of 5.06 indicates that SBC has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 5.06, SBC belongs to the top of the industry, outperforming 93.07% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.1
Quick Ratio 5.06
SBC Yearly Current Assets VS Current LiabilitesSBC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. SBC Growth Analysis

3.1 Past

  • SBC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 48.69%, which is quite impressive.
  • Looking at the last year, SBC shows a quite strong growth in Revenue. The Revenue has grown by 10.85% in the last year.
EPS 1Y (TTM)48.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%300%
Revenue 1Y (TTM)10.85%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-18.33%

3.2 Future

  • Based on estimates for the next years, SBC will show a decrease in Earnings Per Share. The EPS will decrease by -0.28% on average per year.
  • SBC is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.61% yearly.
EPS Next Y-25.49%
EPS Next 2Y-8.79%
EPS Next 3Y-0.28%
EPS Next 5YN/A
Revenue Next Year-17.72%
Revenue Next 2Y-6.27%
Revenue Next 3Y-0.61%
Revenue Next 5YN/A

3.3 Evolution

SBC Yearly Revenue VS EstimatesSBC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 50M 100M 150M 200M
SBC Yearly EPS VS EstimatesSBC Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0.2 0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

6

4. SBC Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 6.72, which indicates a rather cheap valuation of SBC.
  • Based on the Price/Earnings ratio, SBC is valued cheaper than 97.03% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 25.73, SBC is valued rather cheaply.
  • SBC is valuated cheaply with a Price/Forward Earnings ratio of 7.26.
  • Based on the Price/Forward Earnings ratio, SBC is valued cheaply inside the industry as 95.05% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 23.72. SBC is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 6.72
Fwd PE 7.26
SBC Price Earnings VS Forward Price EarningsSBC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • SBC's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. SBC is cheaper than 95.05% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.46
SBC Per share dataSBC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-8.79%
EPS Next 3Y-0.28%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SBC Dividend Analysis

5.1 Amount

  • No dividends for SBC!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SBC Fundamentals: All Metrics, Ratios and Statistics

SBC MEDICAL GROUP HOLDINGS I

NASDAQ:SBC (3/19/2026, 8:00:02 PM)

After market: 3.63 0 (0%)

3.63

+0.13 (+3.71%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-14
Earnings (Next)03-27
Inst Owners1.3%
Inst Owner ChangeN/A
Ins Owners90.38%
Ins Owner Change0%
Market Cap372.37M
Revenue(TTM)178.46M
Net Income(TTM)43.32M
Analysts80
Price Target8.33 (129.48%)
Short Float %3.32%
Short Ratio11.52
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-38.66%
Min EPS beat(2)-85.33%
Max EPS beat(2)8.01%
EPS beat(4)3
Avg EPS beat(4)5.59%
Min EPS beat(4)-85.33%
Max EPS beat(4)89.02%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.07%
Min Revenue beat(2)-4.16%
Max Revenue beat(2)-3.99%
Revenue beat(4)0
Avg Revenue beat(4)-9.96%
Min Revenue beat(4)-22.64%
Max Revenue beat(4)-3.99%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)1.91%
Revenue NQ rev (1m)0.53%
Revenue NQ rev (3m)0.53%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.34%
Valuation
Industry RankSector Rank
PE 6.72
Fwd PE 7.26
P/S 2.09
P/FCF N/A
P/OCF N/A
P/B 1.5
P/tB 1.69
EV/EBITDA 3.46
EPS(TTM)0.54
EY14.88%
EPS(NY)0.5
Fwd EY13.77%
FCF(TTM)-0.36
FCFYN/A
OCF(TTM)-0.34
OCFYN/A
SpS1.74
BVpS2.42
TBVpS2.14
PEG (NY)N/A
PEG (5Y)N/A
Graham Number5.42
Profitability
Industry RankSector Rank
ROA 13.48%
ROE 17.47%
ROCE 26.89%
ROIC 21.24%
ROICexc 39.36%
ROICexgc 48.54%
OM 41.7%
PM (TTM) 24.28%
GM 74.09%
FCFM N/A
ROA(3y)11.06%
ROA(5y)N/A
ROE(3y)17.35%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Debt/EBITDA 0.24
Cap/Depr 69.08%
Cap/Sales 1.14%
Interest Coverage 636.56
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.1
Quick Ratio 5.06
Altman-Z 6.03
F-Score5
WACC8.64%
ROIC/WACC2.46
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)48.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%300%
EPS Next Y-25.49%
EPS Next 2Y-8.79%
EPS Next 3Y-0.28%
EPS Next 5YN/A
Revenue 1Y (TTM)10.85%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-18.33%
Revenue Next Year-17.72%
Revenue Next 2Y-6.27%
Revenue Next 3Y-0.61%
Revenue Next 5YN/A
EBIT growth 1Y14.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-14%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1928.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1816.19%
OCF growth 3YN/A
OCF growth 5YN/A

SBC MEDICAL GROUP HOLDINGS I / SBC Fundamental Analysis FAQ

What is the fundamental rating for SBC stock?

ChartMill assigns a fundamental rating of 5 / 10 to SBC.


Can you provide the valuation status for SBC MEDICAL GROUP HOLDINGS I?

ChartMill assigns a valuation rating of 6 / 10 to SBC MEDICAL GROUP HOLDINGS I (SBC). This can be considered as Fairly Valued.


How profitable is SBC MEDICAL GROUP HOLDINGS I (SBC) stock?

SBC MEDICAL GROUP HOLDINGS I (SBC) has a profitability rating of 5 / 10.


How financially healthy is SBC MEDICAL GROUP HOLDINGS I?

The financial health rating of SBC MEDICAL GROUP HOLDINGS I (SBC) is 7 / 10.


Can you provide the expected EPS growth for SBC stock?

The Earnings per Share (EPS) of SBC MEDICAL GROUP HOLDINGS I (SBC) is expected to decline by -25.49% in the next year.